2. Gene
  3. Mif - macrophage migration inhibitory factor (glycosylation-inhibiting factor) Gene

Mif - macrophage migration inhibitory factor (glycosylation-inhibiting factor) Gene

  • Gene
  • Protein
  • Agent
  • Ortholog
Mus musculus

Also known as GIF; DER6; Glif

Gene ID: 17319 | Gene type: protein coding

About Mif

Summary

Enables cytokine activity; phenylpyruvate tautomerase activity; and Protease binding activity. Involved in several processes, including negative regulation of apoptotic process; positive regulation of macromolecule metabolic process; and regulation of signal transduction. Acts upstream of or within DNA damage response, signal transduction by p53 class mediator; cell aging; and regulation of cell population proliferation. Located in extracellular space. Is expressed in several structures, including alimentary system; central nervous system; genitourinary system; respiratory system; and sensory organ. Human ortholog(s) of this gene implicated in allergic disease; asthma; cystic fibrosis; lung disease (multiple); and obesity. Orthologous to human MIF (macrophage migration inhibitory factor). [provided by Alliance of Genome Resources, Apr 2022]

Mif Products(1)

mRNA Protein Name
NM_010798.3 NP_034928.1 macrophage migration inhibitory factor
Protein Preferred Names Protein Names

macrophage migration inhibitory factor

L-dopachrome isomerase

L-dopachrome tautomerase

delayed early response protein 6

phenylpyruvate tautomerase

Recombinant Mif Proteins

Cat. No. Product Name Accession Purity
HY-P7388 MIF Protein, Mouse P34884 (M1-A115) ≥95%
HY-P70341 MIF Protein, Mouse (His) P34884 (P2-A115) ≥95%
HY-P70341AF Animal-Free MIF Protein, Mouse (His) P34884 (M1-A115) ≥95%
HY-P700517 MIF Protein, Mouse (P. pastoris, His) P34884 (P2-A115) ≥95%

Related Agents

Approval
Bioactive Molecules (1)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-17009 Iguratimod Inhibitor 99.93% Yes
Clinical Phase
Bioactive Molecules (1)
Cat. No. Product Name Effect
Purity Phase
HY-16692 ISO-1 Inhibitor 99.94% Phase 1
Inhibitory Antibodies (1)
Cat. No. Product Name Effect
Purity Phase
HY-P99262 Imalumab Inhibitor 98.37% Phase 2
Pre-clinical Phase
Bioactive Molecules (27)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-110063 4-IPP Inhibitor 99.46% Unkown
HY-110095 (±)-CPSI-1306 Antagonist 98.90% Unkown
HY-147390 MIF098 Inhibitor 99.88% Unkown
HY-105077A Nemifitide diTFA 98.01% Unkown
HY-115887 R110 Inhibitor 99.90% Unkown
HY-123814 4-CPPC Inhibitor 99.64% Unkown
HY-107663A MIF-1 TFA Modulator 99.25% Unkown
HY-110084 BTZO-1 99.69% Unkown
HY-W019710 (E,E)-RGFP966 Inhibitor 99.31% Unkown
HY-W164560 RDR 03785 Inhibitor 96.24% Unkown
HY-130332 Mitomycin A Inhibitor 97.3% Unkown
HY-N10096 Epoxyazadiradione 99.21% Unkown
HY-107663 MIF-1 Modulator / Unkown
HY-115888 MIF2-IN-1 / Unkown
HY-144190 MIF-IN-1 Inhibitor / Unkown
HY-144194 MIF-IN-2 Inhibitor / Unkown
HY-144195 MIF-IN-3 Inhibitor / Unkown
HY-144196 MIF-IN-4 hydrochloride Inhibitor / Unkown
HY-146318 MIF-IN-5 Inhibitor / Unkown
HY-146319 MIF-IN-6 Inhibitor / Unkown
HY-148117 MD13 Inhibitor / Unkown
HY-155466 Boc-MIF-1-Am Activator / Unkown
HY-D0039 3-Cyanoumbelliferone / Unkown
HY-P3087 Tyr-W-MIF-1 Modulator / Unkown
HY-RS08445 MIF Human Pre-designed siRNA Set A Pre-designed Sets / Unkown
HY-149308 MKA031 Inhibitor / Unkown
HY-U00271 Pareptide monohydrochloride / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens Mif NCBI NCBI:4282